ARCHIVES

FDA To Expand Disclosure For Advisory Committee Members

This article is from The Cancer Letter archive.

Vol. 36 No. 15 | April 23, 2010

Download PDF Visit The Full Archive

Related Articles

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”

July 27, 1984

NCI Cooperative Group Clinical Trials Approved

July 31, 2009

Rall, FDA Chief On AACR Panel

April 27, 1979

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991